Module 5: The impact of residual risk
- https://www.acc.org/latest-in-cardiology/articles/2019/10/06/24/42/addressing-residual-risk-in-secondary-prevention
- https://www.researchgate.net/profile/Satya-Dash-2/publication/332531456_Residual_cardiovascular_risk_among_people_with_diabetes/links/5e9a127b299bf13079a249fd/Residual-cardiovascular-risk-among-people-with-diabetes.pdf
- https://www.nature.com/articles/ncpendmet0398
- https://pubmed.ncbi.nlm.nih.gov/28833481/
- https://www.r3i.org/publications.php
- https://academic.oup.com/ndt/article/32/10/1705/3059441
- https://www.ahajournals.org/doi/10.1161/ATVBAHA.118.311999
- https://openheart.bmj.com/content/5/1/e000722
Knowledge test Summary
0 of 7 Questions completed
Questions:
Information
You have already completed the knowledge test before. Hence you can not start it again.
Knowledge test is loading…
You must sign in or sign up to start the knowledge test.
You must first complete the following:
Results
Results
0 of 7 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 7
1. Question
A comprehensive analysis of randomised controlled trials in Europe, Latin America, and Asia-Pacific, alongside real-wold data from EMR database, found failure to reach glycaemic targets in what percentage of patients, respectively?
CorrectIncorrect -
Question 2 of 7
2. Question
The residual risk that remains with lipid-lowering agents is ___?
CorrectIncorrect -
Question 3 of 7
3. Question
In patients with cardiovascular disease, the vascular bed involvement with the highest estimated 10-year residual risk is?
CorrectIncorrect -
Question 4 of 7
4. Question
The reduction in relative risk of mortality with mineralocorticoid receptor antagonist vs placebo for the treatment of heart failure in the RALES trial is ___?
CorrectIncorrect -
Question 5 of 7
5. Question
Following treatment for risk factors, residual risk is highest in patients with Type 2 diabetes and ____?
CorrectIncorrect -
Question 6 of 7
6. Question
Despite intensive treatment in the STENO-2 trial, ___ of patients progressed from microalbuminuria to proteinuria at 13.3 years.
CorrectIncorrect -
Question 7 of 7
7. Question
Among patients with Type 2 diabetes and cardiovascular disease, what percentage were on optimal medical therapy in a study of 5006 patients at 119 centres in the US?
CorrectIncorrect